VGH:CA:TSX-Vanguard US Dividend Appreciation CAD Hedged (CAD)

ETF | US Equity |

Last Closing

CAD 61.78

Change

+0.32 (+0.52)%

Market Cap

CAD 0.78B

Volume

7.19K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-30 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.27 (-0.20%)

CAD 21.09B
ZSP:CA BMO S&P 500

-0.27 (-0.32%)

CAD 17.10B
XSP:CA iShares Core S&P 500 (CAD Hedg..

N/A

CAD 11.46B
VUN:CA Vanguard US Total Market

-0.21 (-0.20%)

CAD 10.87B
XUS:CA iShares Core S&P 500 Index ETF

-0.11 (-0.23%)

CAD 8.70B
HXS:CA Global X S&P 500 Corporate Cla..

-0.13 (-0.16%)

CAD 4.34B
VSP:CA Vanguard S&P 500 CAD hedged

+0.12 (+0.13%)

CAD 4.04B
QUU:CA Mackenzie US Large Cap Equity ..

-0.86 (-0.39%)

CAD 3.60B
XUU:CA iShares Core S&P US Total Mark..

-0.22 (-0.39%)

CAD 3.34B
ZUE:CA BMO S&P 500 (CAD Hedged)

+0.10 (+0.13%)

CAD 3.23B

ETFs Containing VGH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.06% 84% B 42% F
Dividend Return 0.35% 52% F 19% F
Total Return -2.71% 81% B- 42% F
Trailing 12 Months  
Capital Gain 8.18% 43% F 61% D-
Dividend Return 1.45% 60% D- 26% F
Total Return 9.63% 43% F 57% F
Trailing 5 Years  
Capital Gain 64.05% 37% F 64% D
Dividend Return 9.59% 53% F 17% F
Total Return 73.64% 37% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 9.57% 31% F 67% D+
Dividend Return 10.76% 27% F 65% D
Total Return 1.19% 55% F 42% F
Risk Return Profile  
Volatility (Standard Deviation) 12.43% 71% C- 64% D
Risk Adjusted Return 86.54% 46% F 87% B+
Market Capitalization 0.78B 59% D- 67% D+

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.